Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 22 results:
Author Title Type [ Year(Asc)]
Filters: Author is Hagberg, K. W.  [Clear All Filters]
2016
B. Yang, Hagberg, K. W., Chen, J., Sahasrabuddhe, V. V., Graubard, B. I., Jick, S., and McGlynn, K. A., Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink, Br J Cancer, vol. 115, pp. 85-9, 2016.
B. Yang, Petrick, J. L., Chen, J., Hagberg, K. W., Sahasrabuddhe, V. V., Graubard, B. I., Jick, S., and McGlynn, K. A., Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink, Cancer Epidemiol, vol. 43, pp. 105-11, 2016.
K. W. Hagberg, Sahasrabuddhe, V. V., McGlynn, K. A., and Jick, S. S., Does Angiotensin-Converting Enzyme Inhibitor and beta-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink, Pharmacotherapy, vol. 36, pp. 187-95, 2016.
K. W. Hagberg, Li, L., Peng, M., Shah, K., Paris, M., and Jick, S., Incidence rates of suicidal behaviors and treated depression in patients with and without psoriatic arthritis using the Clinical Practice Research Datalink, Mod Rheumatol, vol. 26, pp. 774-9, 2016.
K. W. Hagberg, Li, L., Peng, M., Paris, M., Shah, K., and Jick, S. S., Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis, J Clin Rheumatol, vol. 22, pp. 241-7, 2016.
K. W. Hagberg, Divan, H. A., Persson, R., Nickel, J. C., and Jick, S. S., Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink, Bmj, vol. 354, p. i4823, 2016.
[Page last reviewed 6 September 2019]